Xeris Pharmaceuticals (XERS) Gets a Buy from Jefferies
at www.tipranks.com (Fri, 9-Jan 8:46 AM)
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
at www.tipranks.com (Fri, 9-Jan 8:35 AM)
Xeris Projects Record 2025 Revenues, Driven by Strong Growth in Recorlev, Gvoke, and Keveyis
Market Chameleon (Thu, 8-Jan 8:41 AM)
at www.tipranks.com (Thu, 8-Jan 9:41 AM)
Xeris Biopharma expects full-year 2025 revenue above estimates
at seekingalpha.com (Thu, 8-Jan 7:51 AM)
Xeris Biopharma Achieves Record Q3 Results as Recorlev Revenue Surges 109%—Guidance Raised for 2025
Market Chameleon (Thu, 6-Nov 7:59 AM)
